通过分子对接,GaMD模拟,相关性网络分析和MM-GBSA计算来识别SARS-CoV2-3CLpro 抑制剂的结合机制
Jianzhong Chen1, Jian Wang1, Wanchun Yang1
1School of Science, Shandong Jiaotong University, Jinan 250357, China.
Molecules (Basel, Switzerland)
|February 26, 2025
概括
计算模拟揭示了小分子如何抑制SARS-CoV-2 3CLpro,这是一个关键的COVID-19目标. 结果突出了特定的蛋白质残留物,这些残留物对于设计有效的抗病毒药物至关重要.
科学领域:
- 生物化学 生物化学
- 计算生物学 计算生物学
- 药物发现 药物发现 药物发现
背景情况:
- SARS-CoV-2 主蛋白酶 (3CLpro) 对于病毒复制至关重要,也是COVID-19治疗的主要标.
- 了解小分子抑制3CLpro的分子机制对于开发有效的抗病毒药物至关重要.
研究的目的:
- 使用先进的计算方法研究3CLpro在抑制剂结合时的结构动力学.
- 为了确定关键的残留物和相互作用,参与调节3CLpro活性,以合理的药物设计.
主要方法:
- 高斯加速分子动力学 (GaMD) 模拟用于增强形态采样.
- 相关联网络分析 (CNA) 以绘制域间通信的地图.
- 正常模式分析 (NMA) 和主要组件分析 (PCA) 用于灵活性和集体运动分析.
- 具有泛化的波恩表面积 (MM-GBSA) 的分子力学和量子力学/分子力学 (QM/MM-GBSA) 用于结合自由能计算.
主要成果:
- 在3CLpro域II中的一个特定节点被确定为在抑制剂结合后从催化部位到域III的结构变化的关键调解者.
- 抑制剂结合显著改变了催化站点和域III的结构灵活性和集体运动.
- 有约束力的自由能量计算显示了与实验数据的高相关性,验证了模拟方法.
- 特定的残留物 (L27, H41, C44, S46, M49, N142, G143, S144, C145, H163, H164, M165, E166) 被确定为抑制剂相互作用的关键.
结论:
- 该研究阐明了3CLpro抑制的全性机制,揭示了小分子如何通过结构变化调节酶活性.
- 鉴定的关键残留物为设计用于COVID-19治疗的新型和强效3CLpro抑制剂提供了有价值的目标.
- 像GaMD和CNA这样的计算方法是了解酶动态和指导药物发现工作的有效工具.
相关概念视频
Enzyme Inhibition
95.2K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
95.2K
Ligand Binding Sites
15.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
15.8K
Protein-protein Interfaces
15.0K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
15.0K
The Equilibrium Binding Constant and Binding Strength
15.6K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
15.6K
Protein-Drug Binding: Mechanism and Kinetics
2.1K
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
2.1K
Inhibitors of Viral Protein Synthesis
32
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
32


